« Previous Next » The Journal of Heart and Lung Transplantation
Volume 29, Issue 11 , Pages 1312-1314 , November 2010

Usefulness of sirolimus-based immunosuppression in ameliorating pre-transplant renal dysfunction in patients with Chagas' heart disease

Reinaldo B. Bestetti, MD, PhD, FESC
- Division of Cardiology, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, SP, Brazil
Tatiana A.D. Theodoropoulos, MD, PhD
- Division of Cardiology, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, SP, Brazil
Marcelo A. Nakazone, MD
- Division of Cardiology, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, SP, Brazil
Denis A.N. Dourado, MD
- Division of Cardiology, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, SP, Brazil
Emmanuel A. Burdmann, MD, PhD
- Division of Nephrology, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, SP, Brazil

References

Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant. 2006;25:1024–1042
Meiser B, Reichart B, Adamidis I, Uberfuhr P, Kaczmarek I. First experience with de novo calcineurin inhibitor-free immunosuppression following cardiac transplantation. Am J Transplant. 2005;5:827–831
- MEDLINE
- CrossRef
González-Vílchez F, de Prada JA, Exposito V, et al. Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure. J Heart Lung Transplant. 2008;27:1135–1141
Bertolino ND, Villafanha DF, Cardinalli-Neto A, et al. Prognostic impact of Chagas' disease in patients awaiting heart transplantation. J Heart Lung Transplant. 2010;29:449–453
Bestetti RB, Theodoropoulos TA. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail. 2009;15:249–255